Enjaymo

Indicated For

Cold Agglutinin Disease

About This Medication

# ENJAYMO Patient Solutions Patient Guide: How to Get Enjaymo (sutimlimab-jome) at Low or No Cost Enjaymo (sutimlimab-jome) is the first and only FDA-approved treatment for hemolysis in adults with cold agglutinin disease (CAD), a rare autoimmune disorder where cold temperatures trigger antibodies that destroy red blood cells, leading to anemia, fatigue, and other symptoms.[3][8] The **ENJAYMO Patient Solutions** program from **Recordati Rare Diseases** offers financial help, including a No Cost Trial Program, Patient Assistance Program, and Copay Assistance Program, to make treatment accessible for eligible patients facing insurance or financial barriers.[1][2] ## Who Qualifies for ENJAYMO Patient Solutions? This program supports adults with CAD who need Enjaymo but face hurdles like high costs or insurance gaps. Key eligibility factors include: - **Diagnosis**: Confirmed cold agglutinin disease (CAD) with hemolysis (red blood cell destruction).[3][7] - **Insurance Status**: Commercial insurance for copay help; uninsured or underinsured may qualify for free medication via the Patient Assistance Program or No Cost Trial.[1][2] - **Financial Need**: No strict income limits—eligibility focuses on insurance issues and financial challenges rather than Federal Poverty Level (FPL) percentages.[1][5] **No Cost Trial Program**: New patients can get a **30-day supply of Enjaymo at no cost**, regardless of insurance. Enrollment in ENJAYMO Patient Solutions is required, with no obligation to continue.[1][2][3] **Patient Assistance Program**: Free or low-cost Enjaymo for those with limited access due to insurance or finances.[1][5] **Copay Assistance Program**: Reduces out-of-pocket costs (copays, coinsurance, infusion fees) to as low as **$0**, up to **$25,000 annually** for commercial insurance patients.[2] ## About Enjaymo (sutimlimab-jome) Enjaymo is a monoclonal antibody given by intravenous (IV) infusion. It targets the complement system to block hemolysis in CAD, helping improve hemoglobin levels, reduce fatigue, and decrease the need for blood transfusions.[3][6][7] Administered initially every 2 weeks, then every 4 weeks, it's infused in a doctor's office, infusion center, or at home via CVS Pharmacy.[1][4] **Important Safety Note**: Discuss risks like infusion reactions, infections, or autoimmune issues with your doctor. Enjaymo is not for government insurance patients through copay programs.[2] ## Income Eligibility Breakdown Unlike many programs, ENJAYMO Patient Solutions has **no specific income thresholds** (e.g., no 400% FPL cap). Decisions are based on individual financial hardship and insurance status.[1][5] Here's a simple overview: | Program Option | Income Requirements | Insurance Needed | Max Benefit | |-----------------------------|--------------------------------------|-----------------------------------|---------------------------------| | **No Cost Trial** | None listed; financial challenges | Any (including none) | 30-day free supply | | **Patient Assistance** | Based on financial challenges | Uninsured/underinsured | Free/low-cost Enjaymo | | **Copay Assistance** | Not income-based; financial need | Commercial only | $25,000/year | Contact the program for a personalized assessment—proof of income is required.[1][2] ## Insurance Requirements - **Commercial Insurance Only** for Copay Program: Not for Medicare, Medicaid, VA, DOD, TRICARE, or state programs.[2] - **Uninsured/Underinsured**: Qualify for Patient Assistance or Trial Program.[1][4] - Some insurers require prior authorization; Case Managers help navigate this.[1][7] ## Step-by-Step Application Process 1. **Talk to Your Doctor**: Get a prescription for Enjaymo and discuss if CAD treatment fits your needs.[3] 2. **Call ENJAYMO Patient Solutions**: Dial **(833) 223-2428** to enroll. Case Managers guide you.[1][4] 3. **Submit Documents**: Provide: - Proof of residency (e.g., utility bill) - Proof of income (e.g., tax returns, pay stubs) - Insurance info (card, policy details) - Prescription from your doctor[1][5] 4. **Enroll in a Program**: Choose Trial, Assistance, or Copay based on your situation.[1][2] 5. **Approval and Start**: Once approved, medication ships. Reauthorization needed for ongoing therapy.[7] Applications start by phone—no online form listed.[1] ## Timeline and Delivery - **Processing Time**: Not specified; Case Managers provide updates. Trial Program starts quickly for eligible patients.[1] - **Delivery Options**: - Shipped to your home - Physician's office - Infusion center - At-home via CVS Pharmacy (subject to eligibility)[1][4] - **Refills/Reauthorization**: Required periodically; show response (e.g., better hemoglobin) for continuation.[7] ## Alternatives if Denied - **Appeal**: Work with Case Managers to resubmit or appeal insurance denial.[1] - **Other Programs**: Check general rare disease funds or state assistance (not program-specific). - **No Biosimilars**: Enjaymo has none listed.[7] - **Clinical Trials**: Ask your doctor about CAD studies. - **Switch Therapies**: Insurers may cover alternatives, though some view Enjaymo as not first-line.[9] ## Disclaimer This guide is for informational purposes based on available program details as of last update. Eligibility varies; **call (833) 223-2428** for current rules. Recordati Rare Diseases can change programs anytime. Not medical advice—consult your healthcare provider. Not for government insurance copay use.[1][2] (Word count: 928)

Program information last verified: March 30, 2026